跳至主要内容
临床试验/ITMCTR2200005794
ITMCTR2200005794尚未招募4 期

Clinical Observation of Shengui Capsule Intervention in Heart Failure with Preserved Ejection Fraction

Dongzhimen Hospital, Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 80(—)
性别
All

入选标准

  • ? Patients with heart failure with preserved ejection fraction who meet the diagnostic criteria and have symptoms who need diuretics and whose cardiac function class (NYHA class) is II to IV;
  • ?Meet the 2019ESC diagnostic criteria for chronic coronary syndrome
  • ? The cause of heart failure in patients with preserved ejection fraction is caused by coronary heart disease;
  • ?Traditional Chinese medicine for heart failure patients with heart-yang insufficiency, qi deficiency and blood stasis;
  • ? Those who received at least 2 weeks of standardized western medicine treatment and reached the optimal dose;
  • ? Those who have not used traditional Chinese medicine/proprietary Chinese medicine for the treatment of heart failure within 2 weeks before enrollment;
  • ?Age between 40-80 years old;
  • ? Those who are in good spirits and able to communicate verbally and in writing;
  • ? The HFpEF patients who signed the informed consent form voluntarily participated in this study.

排除标准

  • ? Under stable conditions, any previous echocardiographic measurement of LVEF = 50%;
  • ? Acute decompensated heart failure within 30 days prior to screening, or acute coronary syndrome (including myocardial infarction), cardiac surgery, other major cardiovascular surgery, or emergency percutaneous coronary intervention within 3 months prior to screening interventional therapy;
  • ? At the time of screening, walking distance was mainly limited by non-cardiac disease;
  • ? History of dilated cardiomyopathy, including perinatal cardiomyopathy, chemotherapy-induced cardiomyopathy or viral myocarditis;
  • ? History of hypertension and poor blood pressure control (systolic blood pressure = 160 mmHg, or diastolic blood pressure = 100 mmHg);
  • ? Patients with glycated hemoglobin>7.5% did not receive diabetes treatment;
  • ? Patients with serious primary diseases such as lung, brain, liver, kidney, hematopoietic system, mental illness, and severe neurosis;
  • ? Patients with Yin deficiency and Yang Sheng with symptoms such as burning skin, five upset hearts, shortness of breath, and constipation;
  • ?Allergic constitution or allergic to known components of the test drug.

研究者

发起方
Dongzhimen Hospital, Beijing University of Chinese Medicine

相似试验

Clinical Observation of Shengui Capsule Intervention... | 临床试验